Ahmad Tasnime Abdo, Houjeiry Samar El, Kanj Souha S, Matar Ghassan M, Saba Esber S
Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
Division of Infectious Diseases, Department of Internal Medicine, Center for Infectious Diseases Research, American University of Beirut Medical Center, Beirut, Lebanon.
J Glob Antimicrob Resist. 2024 Dec;39:231-239. doi: 10.1016/j.jgar.2024.10.259. Epub 2024 Oct 31.
The unregulated use of antibiotics has led to the rise of antibiotic-resistant bacterial strains. This study explores bacteriophage therapy as an alternative treatment, highlighting its history, significance, and advancements in Europe, the United States, and the Middle East.
A comprehensive literature review on bacteriophage therapy was conducted, focusing on its development, clinical trials, and patient treatment applications. The study also examined challenges, limitations, criteria for ideal phage selection, and manipulation techniques.
The United States and several European countries have advanced in phage therapy, progressing from clinical trials to patient treatment, whereas Middle Eastern countries are still in the early stages. Bacteriophages offer specificity, abundance, and minimal side effects, but challenges like safety concerns and potential resistance limit their widespread use.
Bacteriophage therapy shows promise as an antibiotic alternative but faces safety and resistance challenges. Continued research and better regulatory frameworks, especially in the Middle East, are needed to realize its potential.
抗生素的无节制使用导致了抗生素耐药菌株的增加。本研究探讨噬菌体疗法作为一种替代治疗方法,重点介绍其在欧洲、美国和中东地区的历史、意义及进展。
对噬菌体疗法进行了全面的文献综述,重点关注其发展、临床试验及患者治疗应用。该研究还考察了挑战、局限性、理想噬菌体选择标准及操作技术。
美国和几个欧洲国家在噬菌体疗法方面取得了进展,从临床试验发展到患者治疗,而中东国家仍处于早期阶段。噬菌体具有特异性、丰富性和最小的副作用,但安全性担忧和潜在耐药性等挑战限制了它们的广泛应用。
噬菌体疗法作为抗生素替代品显示出前景,但面临安全性和耐药性挑战。需要持续开展研究并建立更好的监管框架,尤其是在中东地区,以实现其潜力。